We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

96 hedge funds and large institutions have $96.6M invested in iShares US Pharmaceuticals ETF in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 30 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $3.01M | Put options by funds: $816K

2% less funds holding

Funds holding: 98 → 96 (-2)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

16.73% less ownership

Funds ownership: 97.45% → 80.72% (-17%)

23% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 30

35% less capital invested

Capital invested by funds: $148M → $96.6M (-$51.1M)

Holders
96
Holders Change
-2
Holders Change %
-2.04%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
23
Reduced
30
Closed
16
Calls
$3.01M
Puts
$816K
Net Calls
+$2.2M
Net Calls Change
+$602K

Top Buyers

1
CG
Colony Group
Massachusetts
+$8.56M
2
BW
Biegel & Waller
Maryland
+$5.91M
3
FWCM
Ferguson Wellman Capital Management
Oregon
+$1.62M
4
Wells Fargo
Wells Fargo
California
+$1.26M
5
Mawer Investment Management
Mawer Investment Management
Alberta, Canada
+$1.14M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$34.3M
2
CIBC World Market
CIBC World Market
Ontario, Canada
-$4.11M
3
Bank of America
Bank of America
North Carolina
-$2.68M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.44M
5
Jane Street
Jane Street
New York
-$1.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$10.9M -$34.3M -670,047 -74%
Brown Advisory
2
Brown Advisory
Maryland
$8.54M -$524K -10,230 -5%
CG
3
Colony Group
Massachusetts
$7.84M +$8.56M +167,052 New
BW
4
Biegel & Waller
Maryland
$5.41M +$5.91M +115,248 New
Wells Fargo
5
Wells Fargo
California
$4.56M +$1.26M +24,549 +34%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$3.97M +$473K +9,219 +12%
Ameriprise
7
Ameriprise
Minnesota
$3.86M +$60.1K +1,173 +1%
Bank of America
8
Bank of America
North Carolina
$3.84M -$2.68M -52,263 -39%
MCM
9
Murphy Capital Management
New Jersey
$3.73M -$83.8K -1,635 -2%
Commonwealth Equity Services
10
Commonwealth Equity Services
Massachusetts
$2.98M +$280K +5,466 +9%
AWA
11
ARS Wealth Advisors
Florida
$2.92M -$474K -9,237 -13%
KCM
12
Karp Capital Management
California
$2.56M -$224K -4,377 -7%
LPL Financial
13
LPL Financial
California
$2.37M -$259K -5,043 -9%
Envestnet Asset Management
14
Envestnet Asset Management
Illinois
$1.93M +$995K +19,407 +89%
UBS Group
15
UBS Group
Switzerland
$1.91M +$68.9K +1,344 +3%
RJA
16
Raymond James & Associates
Florida
$1.88M -$844K -16,464 -29%
ST
17
Spinnaker Trust
Maine
$1.81M -$88K -1,716 -4%
RWP
18
RWA Wealth Partners
Massachusetts
$1.55M -$194K -3,786 -10%
FWCM
19
Ferguson Wellman Capital Management
Oregon
$1.49M +$1.62M +31,650 New
BTS
20
BB&T Securities
Virginia
$1.43M +$231K +4,515 +17%
CAN
21
Cetera Advisor Networks
California
$1.38M -$66.7K -1,302 -4%
Stifel Financial
22
Stifel Financial
Missouri
$1.05M -$36.9K -720 -3%
Mawer Investment Management
23
Mawer Investment Management
Alberta, Canada
$1.04M +$1.14M +22,200 New
PP
24
Patten & Patten
Tennessee
$1.02M -$54.6K -1,065 -5%
CFA
25
Cahill Financial Advisors
Minnesota
$1M +$5.38K +105 +0.5%
1
2 3 4 5

IHE Hedge Fund Activity: Q4 2018 in Review

96 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q4 2018, worth a combined $96.6M — down 35% from $148M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of IHE and 14 opened new positions — a net loss of 2 holders — while 30 trimmed existing stakes and 23 added.

The largest buyer was Colony Group, opening a new position worth an estimated $8.56M. The largest seller was Morgan Stanley, cutting an estimated $34.3M.

  • 96 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q4 2018, down from 98 in Q3 2018.
  • Funds reported $96.6M of iShares US Pharmaceuticals ETF stock for Q4 2018, down 35% quarter-over-quarter.
  • 14 funds opened new iShares US Pharmaceuticals ETF positions in Q4 2018 and 16 closed out, a net change of -2 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q4 2018 was Colony Group, an estimated $8.56M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q4 2018 was Morgan Stanley, an estimated $34.3M sold.

Based on aggregated 13F filings for Q4 2018.